🇺🇸 FDA
Patent

US 7202262

Benzoic acid or benzoate substituted 1,2,4-oxadiazole compounds and their use for the treatment of disease

granted A61KA61K31/4245A61K31/4439

Quick answer

US patent 7202262 (Benzoic acid or benzoate substituted 1,2,4-oxadiazole compounds and their use for the treatment of disease) held by PTC THERAPEUTICS, INC. expires Mon Apr 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PTC THERAPEUTICS, INC.
Grant date
Tue Apr 10 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/4245, A61K31/4439, A61K31/454, A61K31/4545